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ABSTRACT: Combinatorially synthesized materials, espe-
cially cationic polymers (CPs), with gene transfection
function hold great promise in nanotechnology. However,
the main limitations of the existing CPs [such as
polyethylenimine (PEI), poly-L-arginine, or polyamidoamine-
based dendrimers] as gene transfection agents are high
cytotoxicity in the physiological environment. We have
developed novel CPs composed of polyaminesendogeneous
tetraamine spermine (Spm) and synthetically made triamine
N-(2-aminoethyl)-1,3-propanediamine (Apd) for incorporat-
ing sec-amino groups and imparting PEI-like structure to the
CP backbones. Naturally occurring building blocks such as
amino acid arginine (R) was also used for incorporating
guanidine-groups into the CPs. The cytotoxicity of resulting CPspolyureas (PUs) and polyamides such as polysuccinamides
and R-attached polymalamides was evaluated using murine and human fibroblasts and carcinoma cell lines. The cell
compatibility screening revealed that the CPs made of Apd are less cytotoxic compared to Spm-based analogues. From the
novel polymer library, total of six polymers were further studied for oligonucleotide (pDNA) complexation and transfection
abilities. Highly water-soluble CPs formed nano-sized polyplexes with pDNA at rather low CP/pDNA weight ratios and showed
less cytotoxicity and higher transfection ability compared to widely used PEI as well as commercially available transfection
agents. Furthermore, new CPs showed selective transfection activity toward certain cell lines (4T1, HeLa, NIH3T3, and CCD
27SK), which is important for their potential applications in gene therapy.
■ INTRODUCTION
The importance of cationic polymers (CPs) is universally
recognized because they exhibit unique biological properties.
CPs can form electrostatic complexes with anionic biomolecules
including nucleic acids and proteins and are of interest as active
biological compound carriers to be used in both gene therapy
and biotechnology. In addition, inherent bioactive properties
such as antimicrobial, antioxidant, antitumor, and anti-
inflammatory stimuli responsiveness make CPs more promising
for enhanced therapeutic potential.1,2 CPs that can be cleared
from the body following executing their function, that is
biodegradable, look especially valuable.
Intracellular delivery of oligonucleotides is one of the major
challenges for the successful gene therapy of serious illnesses
including certain viral infections, inherited disorders, and
cancer.3 Many biological barriers need to be conquered to
achieve safe and efficient delivery of nucleic acids to the
cytoplasm or nuclei of target cells. The main steps of this
promising restorative approach are (i) the protection of the
nucleic acid in the circulation from DNase and RNase mediated
degradation, (ii) effective extravasation to the target tissue, (iii)
successful internalization by the target cells, (iv) endosomal
escape and cytoplasmic release of intact oligonucleotide and its
subsequent transfer inside the nucleus (in case of pDNAs), and
(v) for some applications its integration into the genome of the
host cell. Various viral vectors which can mediate gene transfer
with high efficiency being used to solve the mentioned tasks.
However, the acute immune response, immunogenicity, and
insertion mutagenesis have raised serious safety concerns about
commonly used viral vectors.4,5
CPs have also attracted keen attention because of their lower
safety risks and ability to interact with cells effectively.4−12
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Carefully designed CPs easily form complexes with negatively
charged nucleic acids, condensing them into nano-sized
structures.13−15 However, their low transfection efficacy
compared to viral vectors and structure-dependent cytotoxicity
limit their wide therapeutic applications.9 Therefore, the search
of new and more effective CPs as gene carriers remains topical.
There is no doubt that for all the pharmacological applications,
preference should be given to biodegradable CPs which will be
cleared from the body without toxic degradation products after
their function is fulfilled. For that, the building blocks used for
constructing CPs should be nontoxic and physiologically
relevant. From this point of view, the positively charged
naturally occurring moleculespolyamines16 and α-amino
acids look especially promising as building blocks for
constructing CPs.
Polyamines look suitable for constructing CPs having
polyethylenimine (PEI)-like constitutionthe terminal pri-
mary amino groups could be used for constructing macrochains
via step-growth polymerization (polycondensation) and the
secondary amino groups for incorporating PEI-like moieties in
the polymeric backbones. Among many polyamines, the most
widely used for constructing CPs was an endogenous multi-
amino monomertetraamine spermine (Spm). Positively
charged L-arginine (R) is another important building block of
synthetic CPs as well.
A variety of CPs on the basis of Spm were designed as gene
transfection agents via the Michael addition reaction.17−23
While efficient gene transfection with less cytotoxicity was
obtained with these carriers, they could not degrade back to their
original statebiogenic intact Spm, because of their non-
degradable or nondirectly connected degradable linkages (N,N′-
bis-alkylated derivatives of Spm). The highly charged CPs were
also synthesized by conjugation of Spm with oxidized dextran
(via aldehyde groups) with subsequent reduction of the
obtained amine conjugates (Shiff bases) with NaBH4.
24−26
The dextran−Spm polycations were used as an efficient nonviral
vector for in vitro and in vivo gene transfection. Another types of
CPs were synthesized by conjugation of Spm and glutaraldehyde
with subsequent reduction of the obtained Shiff bases with
NaBH4.
27,28 However, the polymeric amines obtained by the
reduction of the intermediate Shiff-base polymers, similar to the
CPs obtained via the Michael addition reaction,17−23 do not
degrade with releasing free Spminstead, alkylated Spm of
unknown physiological activity is released after the hydrolysis of
these polymers.
More promising are polymers releasing free Spm upon
biodegradation such as the Shiff base synthesized by
polycondensation of Spm and pyruvaldehyde (methylglyoxal)29
and the polyamide (PA) composed of Spm and imidazole-4,5-
dicarboxylic acid.30 In the latter case, Spmwas incorporated into
the CP’s backbone through the primary amino groups by means
of hydrolysable 1,2-amide bonds. Such kind of chemical
structure provided the biodegradation of the polymer under
the action of both body fluid (pH 7.4) and endolysosome (pH
5.8),30 the faster in the latter case. The biodegradability of the
polymer could be ascribed to hydrolysis of vicinal (in 1,2
position relative to each other) amide groups due to mutual
intramolecular catalysis (anchimeric assistance).31−33 The intact
free Spm (biogenic amine) is released after such type of
biodegradation that is a basic merit of these polymers as
compared with the CPs above,17−26 in which Spm was
incorporated into the backbones with non-hydrolysable
alkylated primary amino groups. Hence, the most promising
could be considered Spm-based polymers in which Spm is
incorporated into the polymeric backbones via the primary
amino groups by means of hydrolysable chemical bonds.
R-based CPs have also attracted an attention as transfection
agents in recent years owing to findings of Ryser & Hancock34
that only R-rich, and not lysine-rich, histones were able to
transport albumin into tumor cells. It was demonstrated that the
R-based polymers were significantly more effective in internal-
izing by tumor cells compared to polymers of similar chain
lengths composed of lysine, ornithine, or histidine. Since this
finding, guanidine-rich polymers such as poly-R became popular
transfection agents. Poly-R, however, showed rather high
cytotoxicity that is why several research groups prepared other
types of R-enriched carriers35−39 that showed a good cell-
compatibility but limited transfection activity. Besides, most of
these carriers are not biodegradable that meanswill not be
cleared from the body with a desired rate after executing their
function.
Biodegradable R-based (with R in the backbones) cationic
poly(ester amide)s, PEAs, promising as nonviral gene delivery
agents, were reported by Yamanouchi et al.40 However, the
polymers showed a limited water solubility that confines their
applications. To increase the water solubility of the R-based
ester-polymers, ether links were incorporated into their
backbones. A library of R-based ether−ester polymers of various
classes which showed an increased water solubility along with an
excellent cell-compatibility have been created.41
In an alternative approach, R was attached to the polymeric
lateral chains. R-attached biodegradable CPs were obtained by
covalent attachment of arginine methyl ester and agmatine
(decarboxylated arginine) to PEAs containing lateral carboxyl
groups;42 these polymers, however, were insoluble in water that
restricted their application as transfection agents. In an another
approach, R-attached biodegradable cationic poly(ethylene
malamide) was obtained according to one-pot procedure by in
situ covalent attachment of arginine methyl ester to interme-
diary poly(ethylene epoxy-succinamide).43 The CP showed an
excellent cell compatibility and satisfactory transfection activity.
In this study, Spm and R were selected as building blocks for
synthesizing new library of CPs. Another polyaminea
synthetic triamine with shorter polymethylene chainsN-(2-
aminoethyl)-1,3-propanediamine (Apd) was also included in
the library plan for constructing the PEI-like backbones of CPs
for a comparative study. For synthesizing the new CPs, the
solution active polycondensation (SAP) method44,45 was
selected, and two classes of the CPspolyureas (PUs) and
PAs were obtained. At that two types of PAs containing vicinal
amide groupspolyamine based unsubstituted polysuccina-
mides (PSuAs) and polyamine based R-substituted polymala-
mides (RPAs) were synthesized and studied. The latter were
obtained via one-pot/two-step procedure by covalent attach-
ment of R-methyl ester dihydrochloride (RMeC) to the
intermediate polyamine-based epoxy-PSuAs (EPAs), similar to
the procedure reported in ref 43 for the synthesis of R-
substituted poly(ethylene malamide).
■ RESULTS AND DISCUSSION
Monomers. Polyaminestetrafunctional Spm and trifunc-
tional Apd were transformed into the salt monomers SpmT4,
SpmC4, ApdT3, and ApdC3 (Scheme S1), which were
subsequently used as key bisnucleophilic monomers for the
synthesis of a small library of polymers, due to the following
reasons:
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1. The nucleophilic reactivity of the primary amino groups
in the polyamines is higher compared to the secondary
amino groups which are sterically more hindered. Hence,
the polyamines could be considered as potentially
bifunctional monomers capable to form linear (at least
branched but soluble) polymers when observing the
precautions during the polycondensation reaction with
bis-electrophiles. The difference in reactivity of the
primary and secondary amino groups could be increased
by salt formation: after adding an organic base (a proton
acceptor) that is necessary to carry out the polyconden-
sation, protons are more easily removed from the primary
amino groups owing to lower basicity as compared with
the secondary amino groups.
2. Spm is a hygroscopic solid, and Apd is a liquid product
both less convenient to manipulate. All the salts made of
them are solids and less hygroscopic products more
convenient for manipulations. Surprisingly, hydrochlor-
ides were found less hygroscopic than p-toluenesulfo-
natesno weight gain was observed after a 180 min
exposure under atmospheric conditions (Figure S1). The
structures of the salt monomers, depicted in Scheme S1,
were confirmed by elemental analysis and 1H NMR
spectroscopy (see Supporting Information).
R-methyl ester dihydrochloride (RMeC) used for synthesiz-
ing RPAs was synthesized as reported previously.43
Activated diesters such as di-p-nitrophenyl carbonate (NC),
NSu, and NtES (see Scheme S2) were used as bis-electrophilic
monomers for the polymers synthesis due to the following
reasons:
1. The activated diesters are soft acylating agents and it was
expected that they allow a higher selectivity toward the
primary and secondary amino groups. This could farther
increase a probability of the chain growth reaction
through the primary amino groups, thus leading to CPs
close to a linear structure (at least branched but soluble).
2. The activated carbonate NC was used for diisocyanate
free synthesis of PUs via SAP with fatty diamines as
reported in ref 46. The method was applied to the
synthesis of PUs on the basis of Spm and Adp because
diisocyanates of these polyamines are unavailable.
3. The activated diester NSu was used for synthesizing
biodegradable PAs of 1,2-dicarboxylic acidPSuAs.
These kinds of polymers are unavailable through
traditional high- and low-temperature polycondensations,
and they can be obtained via SAP only using soft acylating
agentsactivated diesters of succinic acid.47
4. The activated diester NtES was used for synthesizing
biodegradable PAs of 1,2-dicarboxylic acid (malic acid)
with covalently attached R-methyl ester hydrochloride
(RMeC) via one-pot/two-step procedure as reported in
ref 43.
The characteristics of the used activated diesters NC, NSu,
and NtES were in accordance with the published data.
The activated diesters of 1,2-diacidsNSu and NtES were
selected with the purpose to synthesize PAs with 1,2-amide
bonds in the backbones which are hydrolyzed due to mutual
intramolecular catalysisso called “anchimeric assis-
tance”.31−33
Scheme 1. Structure of the New Spm and Apd-Based Polymers: PUs, PSuAs, Intermediate EPAs, and RPAsa
aAll polymers synthesized were in salts formseither p-toluenesulfonates (T) or hydrochlorides (C); in case of RPAs one hydrochloric acid
molecule (C) belongs to the residue of R-methyl ester, RMeC.
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Polymers. Two classes of polyamine-based heterochain
polymers were synthesized via SAP within the framework of
presented study. Initially, taking into account the polyfunctional
nature of Spm and Apd, and problematic character of the
synthesis of linear (at least branched but soluble) heterochain
polymers using for the chain growth primary amino groups of
the polyamines, we have selected the synthesis of PUs via SAP of
the Spm and Apd (Scheme S3): the only interaction of activated
carbonate such as NC with primary amino groups proceeds via
the intermediate isocyanate (Scheme S3) and results in the
formation of the urea links after the interaction with another
primary amino group;46 the interaction of the intermediate
isocyanate with secondary amino groups cannot be excluded
completely but the rate of this reaction should be much lower
due to higher steric hindrance. The interaction of NC with
secondary amino groups represents a “dead-end” reaction,
which does not lead to the formation of the urea link. We
supposed that this had to farther increase the probability of the
formation of soluble polymers after SAP of NC with the salts of
polyamines. The obtaining soluble PUs (1SpmT or 1SpmC, and
1ApdT or 1ApdC, Scheme 1) confirmed this assumption. After
the successful synthesis of the soluble PUs, we have synthesized
soluble PSuAs (2SpmT or 2SpmC, and 2ApdT or 2ApdC,
Scheme 1) under the similar reaction conditions (Scheme S4).
Finally, we have synthesized the RPAs (RSpmTC or RSpmCC,
and RApdTC or RApdCC, Scheme 1) for incorporating the
guanidine lateral groups into the macromolecules of the CPs.
These RPAs were prepared according to one-pot/two-step
procedure (Scheme S5) as reported previously for the EPAs
composed of 1,2-ethylenediamine.43 The intermediate Spm or
Apd-based EPAs (ESpmT or ESpmC, and EApdT or EApdC in
Scheme 1) were synthesized by polycondensation of NtES with
the salt monomers (Step 1 in Scheme S5).
The detailed protocols of the synthesis of CPs are given in the
Supporting Information. All the polymers were synthesized in
dimethyl sulfoxide solution at a monomer concentration 1.2
mol/L in the presence of 2 mol (per 1 mol of a salt monomer) of
triethylamine (TEA) used as an acid (HCl or TosOH) acceptor.
The polycondensation of the salt monomers with NC and NSu
was started at rt. At this temperature, the SAP reactions were
carried out heterogeneously even after 3 h stirring. Afterward,
the reaction temperature was gradually (in a timeframe of 2 h to
avoid crosslinking) increased up to 80 °C and proceeded for
additional 16 h. Under these conditions, all the reactionmixtures
were homogenized except to the mixtures of chloride salt
monomers SpmC4 and ApdC3 with NCthe synthesis of the
PUs 1SpmC and 1ApdC was carried out heterogeneously until
the end of the polycondensation. The polycondensation
reaction with participating NtES was also started at rt and
homogeneous reaction was proceeded for total 20 h. In this case,
there was no need to elevate the reaction temperature either for
the homogenization reaction or for its accelerationthe epoxy-
monomer NtES is more active as compared with activated
diesters of regular dicarboxylic acids due to intramolecular
catalytic influence of the oxygen atom in α-position from
carbonyl groups.48 This was the first step of the one-pot
procedure resulting in the intermediary EPAs such as ESpmT,
ESpmC, EApdT, and EApdC (Scheme 1). At the second step
(Scheme S5), the intermediary EPAs were interacted in situ with
RMeC at 60 °C for 24 h resulting in the goal RPAs such as
RSpmTC or RSpmCC, and RApdTC or RApdCC (Scheme 1).
The resulting RPAs also represent biodegradable PAs of 1,2-
dicarboxylic acid−polymalamides containing R-methyl ester
attached covalently via α-amino groups to the malamide
residues in β-position (Scheme 1). Degree of transformation
of EPAs determined by 1H NMR was within 60−70 mol % (see
Supporting Information) that satisfactorily coincide with
reported value (75% determined using IR spectrometry).43
The obtained CPs were purified by 4 h dialysis using tubing
with 1000 Da MWCO followed by freeze-drying. The yields
(before and after dialysis) and molecular weight characteristics
(after dialysis) of the CPs are summarized in Table 1. The
structures of the CPs were confirmed by 1H NMR analysis (see
Supporting Information). All the obtained CPs are hygroscopic;
they are well soluble in water and easily form solutions of 200
mg/mL concentration (used as stock solutions in biological
experiments).
The molecular weight characteristics of the obtained new
library of CPs (in total 12 polymers, Scheme 1)Mw, Mn, and
Mw/Mn (dispersity, Đ) measured using the gel permeation
chromatography (GPC) in the hexafluoroisopropanol (HFIP)/
CF3COONa system after dialysis are reported in Table 1. The
weight average molecular weights (Mw) of most of the obtained
CPs are within 1200−7700 Da. The dispersity Đ of some (4 of
12) of the CPs was within 1.50−1.96 that is typical for polymers
obtained via step growth polymerization (polycondensation)
Table 1. Summary of Characterization Parameters of the CPsb
molecular weight characteristics
sample # CP
class of
polymer empirical formula (MM)
yield, % before/after
dialysisa
Mn
(Da)
Mw
(Da) dispersity, Đ
tested for transfection
activity
1 1SpmT PU C25H40N4O7S2 (572.74) 98/38 5771 22 229 3.85 −
2 1SpmC PU C11H26N4OCl2 (265.18) 100/40 6632 25 454 3.84 −
3 lApdT PU C13H21N3O4S (315.39) 98/45 773 1168 1.51 −
4 lApdC PU C6H14N3OCl (179.65) 100/40 1109 4403 3.97 +
5 2SpmT PSuA C28H44N4O8S2 (628.80) 94/47 1948 3687 1.89 −
6 2SpmC PSuA C14H30N4O2Cl2 (321.87) 97/45 595 1843 3.09 −
7 2ApdT PSuA C16H25N3O5S (371.45) 100/50 2417 4741 1.96 +
8 2ApdC PSuA C9H18N3O2Cl (235.71) 95/52 2809 8340 2.97 +
9 RSpmTC RPA C35H59N8O11S2Cl
(867.47)
100/57 2853 25 945 9.09 −
10 RSpmCC RPA C21H41N8O5Cl3 (591.96) 99/67 788 2484 3.15 +
11 RApdTC RPA C23H37N7O8SCl (607.10) 100/58 1015 1519 1.49 +
12 RApdCC RPA C16H30N7O5Cl2 (435.91) 98/65 956 7748 8.10 +
aAfter 4 h dialysis (MWCO 1000 Da). bGPC in HFIP, PMMA standards.
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and could speak the polymer structure is close to linear. Đ of
other CPs was within 2.96−8.93, which could indicate that these
polymers are branched. Mw of these polymers are especially
highup to 25 900, which is also a strong indication that the
polymers are branched. Running ahead, it should be noted that
the CPs with molecular weights (Mw) above 20 000 Da showed
the highest cytotoxicity and were not selected for transfection
study. The observed molecular weights (Mw) of nontoxic
polymers are within 1200−7700 Da. It has to be noted here that
molecular weights of heterochain polymers measured in HFIP/
CF3COONa system are 2−3 times lower than molecular
weights determined in dimethylformamide (DMF).49 Our
attempt to determine the molecular weights of the CPs using
the GPC in DMF failed because the polymers were irreversibly
bound to Styragel columns.
In Vitro Cytotoxicity Experiments. Prior to investigating
the transfection ability of the newly synthesized CPs, we have
evaluated their cytotoxicity to select the candidates showing
high cell compatibility. The studies were performed using two
cancer cell lines, one human (HeLa, human cervical
adenocarcinoma cell line) and one murine (4T1, mouse
mammary gland breast cancer cell line). In addition, two non-
cancerous cell lines, one human (CCD 27SK, human skin
fibroblasts) and one murine (NIH3T3, mouse embryo
fibroblasts), were added to the study to investigate a wide
range of possible working space. The concentration range of the
CPs was 10−0.04 mg/mL. As seen from the results (Figure 1),
the cellular metabolic activity (considering all cell lines used) is
significantly higher for polymers (for numbering CPs see Table
1) #4 and #7 withHeLa cells, polymers #4, #7, and #10with 4T1
cell lines, #4 and #10 with NIH3T3 and #4, #7, #11, and #12
with CCD 27SK cells. Polymer #9 appeared to be significantly
toxic with all cell lines used.
It is known that the cationic molecules or particles are
associated with cytotoxic effects.50 For example, cationic lipids
containing tertiary or quaternary amines result in high
cytotoxicity caused by the interference with critical enzymes
such as protein kinase C.51 However, the toxicity can be partly
weakened by delocalizing the positive charge of the cationic
grouparomatic heterocyclic ring (e.g. pyridine) or guanidine
was found to be significantly less toxic compared to the
ammonium functionality, especially quaternary ammonium
functionality.50 Yingyongnarongkul et al.52 synthesized guani-
dine-containing transfection agents among a library of different
cationic lipids and demonstrated that these compounds were
safer. It has to be emphasized that all the R-based biodegradable
polymers mentioned above40,41,43 were found to be nontoxic for
the tested concentration range (up to 2 mg/mL) and, in some
cases, even slightly enhanced cell growth.
Our results also emphasize the different response of different
cell types to the selection of CPs. Here, we could see the
advantages of the library-based development approach as where
one of the CPs failed in terms of toxicity, the other types of CPs
deemed to be safe. Therefore, we have selected polymers #3, #4,
Figure 1.Cell viability of (a) HeLa, (b) 4T1, (c) CCD 27SK cells after 24 h, and (d) NIH3T3 cells after 48 h with the new CPs within a concentration
range 10.00−0.04 mg/mL. The numbers on graphs correspond to the polymers numbers in Table 1. Cell viability with PEI in a concentration range
2.00−0.01 mg/mL is also given for a comparison. The concentration range for PEI is limited by its solubility in water.
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#7, #8, #10, #11, and #12 for the further biological studies. It
should also be noted that from every family of CPs, at least two
candidates were selected (#3 and #4 from PUs, #7 and #8 from
PSuAs, #10, #11 and #12 fromRPAs) to have a higher possibility
of carrying more CPs to the following steps of evaluation. Table
2 also indicates the cell viability values of the corresponding
polymers at different weight ratios (WR) in the complexes CP/
pDNA as heat map to better visualize the cytotoxicity pattern of
the CPs. The CP #3 (1ApdT) is omitted because it did not form
complexes with pDNA (see Figure 2).
Polymer/DNA Complex Formation Study. The CP/
pDNA complex formation study for selected polymers was
accomplished using gel-retardation assay according the
procedure given in the Experimental Section. As can be seen
from the results (Figure 2), despite the favorable cytotoxicity
profile, polymer #3 could not form complexes with pDNA.
Polymer #4 was able to form complexes only at WR of 25× and
above. In case of polymers #7 and #8, the complex formation
starts at a lower WR of 5×, while polymers #10−12 were able to
bind pDNA and form complexes starting with a WR of 25×;
polymer #11 also forms complexes with pDNA (not shown in
Figure 2 but given in Table 3). Here, we were again able to have a
selection choice due to step-by-step elimination of a CP library.
Results highlight that there is no one-fits-for-all solution to
develop a CP that will have a favorable cytotoxicity profile
among a wide selection of cell types and still able to effectively
complex genetic material.
DNase I Digestion Assay. To further investigate if the
pDNA encapsulation into the selected formulations protects it
from the nuclease activity which otherwise can cause
inactivation of pDNA within minutes of administration, we
performed the DNase digestion assay. pDNAmust be protected
from intracellular degradation prior to reaching its final
destination within the nucleus. The data given in Figure 3
show that the naked pDNA was completely degraded when
exposed to nuclease, while polymer #10 formed the protective
shield for pDNA at WR of 100× and 500×. Polymer #4
protected the pDNA atWR 500×. Polymers #7 and #8 were able
to protect the pDNA from degradation at bothWR tested (100×
and 500×).
Table 2. Cell Viability Values (%) of Corresponding CPs at Different WR Ratios CPs/pDNA
Figure 2. Agarose (0.8%) gel electrophoresis of new CPs/pDNA complexes: (a) lane 2naked pDNA. Lanes 3−7: polymer #3/pDNA WRs
(designated as 1×, 5× etc.), lanes 8−12polymer #4/pDNA. (b) Lane 11 kb+ DNA ladder, lane 2naked pDNA. Lanes 3−7polymer #7/
pDNA, lanes 8−12polymer #8/pDNA. (c) Lane 1naked pDNA. Lanes 2−6: polymer #10/pDNA, lane 71 kb+ DNA ladder, lanes 8−12
polymer #12/pDNA.
Table 3. Particle Size and Zeta Potential of the CPs/pDNA
Complexes with Different WRs
size of complexes CP/pDNA
zeta potential of
complexes
CP/pDNA
CP
sample # WR
eff. diam.
(nm) SD polydispersity mV SD
4 25× 212.8 1.0 0.19 0.01 0.00
100× 50.5 1.7 0.28 9.44 1.35
500× 48.5 2.6 0.31 51.34 5.27
7 25× 117.0 5.7 0.36 22.60 3.40
100× 77.5 6.6 0.48 24.51 1.23
500× 78.0 4.6 0.40 40.20 5.05
8 25× 59.0 2.2 0.20 0.00 0.00
100× 56.5 2.9 0.37 19.15 3.15
500× 65.7 2.0 0.38 31.19 3.85
10 25× 312.0 2.4 0.13 8.11 1.59
100× 44.0 1.3 0.16 24.14 0.66
500× 38.8 1.3 0.27 57.43 12.07
11 25× 84.3 5.4 0.66 34.11 1.91
100× 75.1 3.5 0.42 34.09 6.41
500× 72.7 5.5 0.32 44.54 0.98
12 25× 68.1 5.1 0.80 23.34 1.20
100× 47.2 3.5 0.45 32.53 4.33
500× 38.0 3.8 0.41 35.035 5.03
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Characterization of Polyplexes. The size and zeta
potential of the complexes obtained were analyzed by the
quasi-electric light scattering (QELS). As can be seen from the
results given in Table 3, all complexes are nano-sized (38−312
nm) and have a positive surface charge. High zeta potential
values are also a strong indicative of electrostatic stabilization of
the nanocomplexes. Although the complexes for polymers #7
and #8 were formed at WR 5× (Figure 3), but the complex size
and zeta potential results received only fromWR 25×. It should
also be noted that for the tested complexes the zeta potential
values are increasing with the increased WR of CP in the
complex (Figure 4). This suggests that following complete
encapsulation of pDNA by corresponding CPs, the excess
polymer chains (positively charged) aligning themselves on the
outer surface of the nanocomplexes and cover it layer by layer,
hence increasing the overall positive charge.
Cellular Uptake of the Polymer/pDNA Complexes. The
ability of CPs to deliver pDNA was investigated by flow
cytometry analysis using eGFP-encoding pDNA. Transfection
experiments of selected CPs were carried out with 4T1, HeLa,
NIH3T3, and CCD 27SK cells. The CPs which are able to form
the complexes with pDNA were selected based on the
cytotoxicity, complex formation, and pDNA protection results.
TheCPs andWRs resulted in 90% and higher cell viability values
were selected for testing (Table 2).
As can be seen from the Figure 5, polymer #10 with WR of
100× and 500× reveals a higher transfection efficiency as
compared to the other polymers and commercially available
transfection agentDharmaFECT, in murine cell lines. Cells
without any additions (controls) and with a free plasmid DNA
addition showed negligible transfection in all cases. A significant
increase in the percent of eGFP-positive cells was observed with
increasing WR at almost all cases. On the other hand, for HeLa
human cancer cell line polymer #7 resulted in better transfection
compared to #4. More importantly, polymers #4 and #7, which
both transfected the HeLa cells efficiently, did not cause any
eGFP expression on noncancerous human skin fibroblast cell
line. This selective transfection ability profiles strongly
emphasizes the importance of selecting correct polymer for
the correct application. By developing a library of novel CPs, we
were able to identify the individual polymers for find the balance
between cytotoxicity, complex formation, pDNA protection,
and effective transfection for different types of cell lines (Table
4).
Confocal Microscopy Study. eGFP expression of HeLa
cells following transfection by polymer #4 and #7 was also
monitored by confocal microscopy. A Zeiss Confocal LSM 700
was used to obtain DIC and fluorescent images of cells (Figure
6). It should be noted that, for successful transfection, several
barriers must be overcome even in in vitro settings. First, the
pDNA must be delivered inside the cells. For that, complex
formation with positively charged CPs was proven to be
significantly beneficial. However, following internalization, the
CPs must be able to release their pDNA cargo inside the
cytoplasm in its intact form, rather than forming a strong
complex that is not able to detach from pDNA. Flow cytometry
and microscopy studies support each other and strongly indicate
that the carefully selected CPs from a small library of polymers
were able to provide all the required properties as effective
transfection agents.
■ CONCLUSIONS
A library of new highly water-soluble CPs were designed and
synthesized on the basis of naturally occurring building blocks
such as amino acid arginine (R), endogeneous tetraamine
Spm and synthetically made triamine Apd. Twelve new
polyamine-based CPs of two classesPUs and PAs were
synthesized via SAP. The cytotoxicity of all 12 CPs toward
different cell lines was evaluated to select low-toxic (90% and
more cell viability) candidates for in vitro transfection studies. A
further screening of the selected CPs was done based on the
complex formation with pDNA to evaluate their potential as the
nucleic acid carriers. The samples of the CPs which formed
positively charged (zeta potentials ≤ +57.4 mV) stable
nanocomplexes CPs/pDNA (38.0−312.0 nm) at low WR
(CPs/pDNA 5× to 25×) were considered as nanocarrier
candidates and selected for the transfection experiments on
human and murine cell lines. The ability of selected CPs to
deliver pDNA was further investigated by flow cytometry
analysis and confocal microscopy study using eGFP-encoding
pDNA. This systematic approach to evaluate the synthesized
polymers allowed us to perform a step-by-step elimination
process for identifying the most effective polymers and their
potential as gene carriers. Studies are designed to support each
Figure 3. Agarose (0.8%) gel electrophoresis of DNase I digestion assay. (a) Lane 1 naked pDNA (pEGFP-N1), lane 2 pDNA upon the addition of
DNase I as a control. Lane 3, 5, 7, 9100× and 500×WR of polymer/pDNA complexes. Lane 4, 6, 8, 10the same complexes treated with DNase I.
(b) Lane 1, 3, 5, 7100× and 500× WR of polymer/pDNA complexes. Lane 4, 6, 8, 10the same complexes treated with DNase I.
Figure 4. Zeta potential vs WR of new CPs/pDNA complexes.
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other, and our reported results strongly indicate the selective
transfection ability profiles of the CPs tested. It should be noted
that for complex gene delivery applications, there is no one-fits-
all polymer/carrier type for variety of tissues andmalignancies to
be treated. However, our results indicate that the carefully
selected CPs from a small library of polymers were able to
provide all the required properties for different cell types as
effective transfection agents. Hence, we believe that the newCPs
have a potential for the applications in gene therapy and
biotechnology as nontoxic and effective agents for intracellular
delivery of nucleic acids.
■ EXPERIMENTAL SECTION
Materials.All chemicals were purchased from Sigma-Aldrich
(St. Louis, MO, USA) unless otherwise stated. PEI (Mw 25 kDa)
was purchased from Polysciences, Inc. (Warrington, PA). The
CellTiter-Blue Cell Viability Assay was obtained from Promega
(Madison, WI, USA). Plasmid DNA−green fluorescence
protein reporter gene (pEGFP-N1) was produced and
purchased from Elim Biopharmaceuticals, Inc. (Hayward, CA,
Figure 5. (a) HeLa, (b) 4T1, (c) NIH3T3 and (d) CCD 27SK cells analyzed for GFP expression after 48 h total transfection using flow cytometer:
controluntreated cells, free pDNA used as a negative control, DharmaFECT and Lipofectaminecommercially available transfection agent. 25×,
100×, 500× are WRs of CP/pDNA. Flow-cytometry results indicate mean ± SD, n = 3, 10 000 events/repetition, 1 μg pDNA/30 000 cells. The CPs
numbers corresponds to those given the Table 1. All comparisons were performed against the no-treatment control. The error bars represent mean ±
SD, n = 3 (***P < 0.005, ****P < 0.0005).
Table 4. Selective Transfection Activity of New CPs toward
Certain Cell Lines
transfection efficiency, %
CP sample # HeLa 4T1 NIH3T3 CCD 27SK
4 high low high low
7 high low a low
10 a high high a
11 a a a high
12 a a a high
aNot tested due to increased cytotoxicity toward these cell lines.
Figure 6. Confocal microscopy images of cellular interaction of different complexes with HeLa cells after 48 h incubation.
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USA). DNase I enzyme (1×) supplied with DNase I Buffer
(10×) and 50 mM ethylenediaminetetraacetic acid (EDTA)
were purchased from Fisher BioReagents (Pittsburgh, PA, US).
Cell Cultures. All cell lines 4T1 (murine mammary
carcinoma), HeLa (human cervical adenocarcinoma),
NIH3T3 (mouse fibroblast), and CCD 27SK cells (human
fibroblast) were obtained from American Type Culture
Collection (ATCC, Manassas, VA, USA) and were grown at
37 °C in 5% CO and 95% humidity in Dulbecco’s modified
Eagle’s medium or in RPMI1640 (Gibco, Life Technologies,
Carlsbad, CA, USA), supplemented with 10% heat-inactivated
fetal bovine serum (Atlanta Biologicals, Flowery Branch, GA),
50 U/mL penicillin, and 50 μg/mL streptomycin (Corning/
Mediatech, Manassas, VA, USA). Whenever required, cells were
harvested by trypsinization with 0.5% trypsin in phosphate-
buffered saline (PBS) containing 0.25% EDTA (Corning/
Mediatech, Manassas, VA, USA).
Methods. Synthesis of Monomers and Polymers. The
synthesis of the polyamine-based polymers via the SAP followed
three major steps:
(1) Preparation of key nucleophilic monomerssalts of
polyamines such as tetra-p-toluenesulfonate and tetrahy-
drochloride of Spm, and tri-p-toluenesulfonate and
trihydrochloride of Apd labeled as SpmT4, SpmC4,
ApdT3, and ApdC3, accordingly. A detailed procedure for
preparing and the general characteristics of the salt
monomers are provided in the Supporting Information.
(2) Synthesis of two classes of bis-electrophilic monomers: (i)
two activated diesters of dicarboxylic acidsdi-p-nitro-
phenyl succinate (NSu) and di-p-nitrophenyl-trans-epoxy
succinate (NtES) and (ii) one activated diester of
carbonic acidNC. Information about the synthetic
and the basic characteristics of the activated diester
monomers are provided in the Supporting Information.
(3) Synthesis of Spm and Apd-based polymers (Scheme 1) by
polycondensation of NC, NSu, and NtES with bisnucleo-
philic salt monomers according to step 1 (see Scheme S3).
The following polymers in forms of either p-toluenesul-
fonates or hydrochlorides were obtained: (i) PUs, and
PAs(ii) PSuAs and (iii) RPAs. The latter were obtained
by the one-pot/two-step synthetic strategyby poly-
condensation of NtES with the salt monomers at the step
1, and by in situ interaction of intermediate EPAs with
RMeC at the step 2 as depicted in Scheme S3. The details
of the synthesis of these polymers are provided in the
Supporting Information.
To avoid long polymer names, we introduce the following
abbreviations for the three classes of polyamines-based polymers
(Scheme 1):
For Spm and Apd-based PUs: 1SpmT, 1SpmC, 1ApdT, and
1ApdC, where 1 corresponds to the carbonic acid residue
(−CO−), T means p-toluenesulfonate, and C means chloride,
accordingly.
For Spm and Apd-based PSuAs: 2SpmT, 2SpmC, 2ApdT, and
2ApdC, where 2 corresponds to the succinic acid residue, T
means p-toluenesulfonate, and C means chloride, accordingly.
For Spm and Apd-based intermediate EPAs: ESpmT,
ESpmC, EApdT, and EApdC, where E corresponds to the
epoxy-succinic acid residue, T means p-toluenesulfonate, and C
means chloride, accordingly.
For Spm and Apd-based RPAs with covalently attached
RMeC: RSpmTC and RSpmCC means RMeC attached to the
Spm-based epoxy-PAs which were in either p-toluenesulfonate
(ESpmT) or chloride (ESpmC) forms, accordingly. RApdTC
and RApdCCmeans RMeC attached to Apd-based EPAs, which
were in either p-toluenesulfonate (EApdT) or chloride
(EApdC) forms, accordingly.
Characterization of Monomers and Polymers. The salt
monomers were characterized by elemental analysis, melting
points (Table S1), and 1H NMR analysis (see Supporting
Information); one of these saltsSpmC4 was reported in the
literature and its melting point well coincided with reported
data. The polyamines and their salts were expected to be
hygroscopic. The hygroscopicity of the free base (Spm) and the
salts SpmT4, SpmC4, ApdT3, and ApdC3 was assessed by
weight gain under atmospheric conditions (see Figure S1). The
chemical structure of the obtained new CPs was confirmed by
NMR spectroscopy (see Supporting Information). The
molecular weight characteristics of the new CPs were measured
in HFIP (from Sigma), solution using a GPC machine
(Shimadzu, model LC-8A) equipped with the LC solution
V.1.25 SP2 software from Shimadzu. A PL HFIP gel column
(Polymer Lab) and a refractive index detector (Shimadzu RID-
10A) were employed. The polymer was dissolved in and eluted
with HFIP containing CF3COONa (0.05 M, to suppress
polyelectrolyte effects). Injected volume: 100 μL, sample
concentration: 2.0 mg/mL, flow rate: 0.5 mL/min. The columns
were calibrated with polymethylmethacrylate (PMMA) stand-
ards. The molecular weight characteristics of the CPs are given
in Table 1.
In Vitro Cytotoxicity. 4T1, HeLa, NIH3T3, and CCD 27SK
cells were seeded in 96-well plates at a density of 5× 103 and 3×
103 cells/well for 24 and 48 h cytotoxicity screening of the
polymers, respectively. Twenty-four hours after seeding, the
culture medium was replaced with fresh complete cell culture
medium containing the various concentrations of polymers.
Following 24 and 48 h continuous treatment with the newly
synthesized polymers as well as polyethyleneimine (PEI), cell
viability was assessed using CellTiter-Blue cell viability assay
according to the manufacturer’s protocol. The relative cell
viability (%) was calculated with cells treated only with the
medium as a control.
Polyplex Formation. Polyplexes were prepared at different
polymer/pDNA (pEGFP-N1) WR between 1 and 500
(designated as 1×, 5×, 25×, 100×, and 500×). Briefly, equal
volumes of polymer solutions from the library and pDNA
solution in Milli-Q water were mixed and vortexed for 10 s. The
mixtures were incubated at room temperature for 30 min.
Whenever sterile polyplexes are needed, the individual polymer
and pDNA solutions were filtered through a 0.2 μm sterile filters
prior mixing and the following steps are carried out in a biosafety
level 2 tissue culture cabinet. The samples were analyzed by gel
electrophoresis on an ethidium bromide-stained E-Gel GP
(0.8%) (Invitrogen, Life Technologies) and after 30 min
migration under 60 V pDNA bands were visualized by UV
transillumination.
Protection from Nucleases. The ability of polymers to
protect the pDNA from the DNase activity was also investigated.
For the DNA digestion assay, the complexes of polymer/pDNA
were incubated for 1 h at 37 °Cwith 2 μL ofDNase I buffer and 1
μL DNase I enzyme in a 50 μL reaction volume. The enzymatic
reaction was terminated by addition of 10 μL 50 mM EDTA
solution followed by incubation at 65 °C for 10 min. For the
release of pDNA from polyplexes, heparin (50 units/μg of
pDNA) was added and the mixtures were further incubated for
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25 min at 37 °C. The samples were electrophoresed under the
same conditions described previously to follow the integrity of
pDNA.
Size and Zeta Potential Study of Complexes. The size and
zeta potential of complexes were determined by the QELS using
a Zeta Plus Particle Analyzer (Brookhaven Instruments Corp,
Santa Barbara, CA) equipped with theMulti-Angle Option at an
angle of 90° at room temperature. Measurements were
performed after diluting the samples with Milli-Q water and
with count rates of approximately 100−400 kcps for each
sample. Average values were calculated from at least 10 runs.
Cellular Uptake of the Polymer/pDNA Complexes. Trans-
fection experiments of selected CPs were carried out with 4T1,
HeLa, NIH3T3, and CCD 27SK cells. In a typical experiment,
12-well tissue culture plates were seeded with 30× 103 cells/well
in 1 mL of medium and incubated for 24 h prior to transfection.
The polymer/pDNA complexes were prepared as described
earlier. The cells were incubated with complexes in serum-free
medium for 6 h at 37 °C. Naked pDNA was used as a negative
control. Complexes obtained with DharmaFECT were used for
comparison. After 6 h of incubation, the medium was removed,
and cells were washed and incubated with 1 mL of the complete
medium for additional 42 h to allow the expression of eGFP
protein. After that the cells were washed, harvested by
trypsinization, and centrifuged at 400g for 5 min. The cell
pellets were rinsed once with cold PBS, resuspended in 300 μL
of cold PBS, and maintained on ice until the analysis. Data
acquisition was performed on a Becton Dickinson FACScan
flow cytometer (Becton Dickinson, San Jose, CA, USA) at the
emission wavelength of 520 nm (channel FL-1). For each
sample, cell debris and dead cells were gated out and 10 000 alive
cell counts were analyzed. Cell-associated fluorescence
intensities were expressed as the average of these measurements
(n = 3).
Confocal Microscopy Study. For confocal microscopy study,
HeLa cells were seeded on coverslips (Fisher Scientific,
Pittsburgh, PA, USA) at a density of 30 × 103 cells/well in 1
mL of RPMI and incubated for 24 h prior to transfection. Cells
were treated with the polymer/pDNA complexes at WR of 25×,
100× and 500×, or with an equal amount of free aqueous
solutions of polymers. After 6 h of incubation, the medium was
removed, and cells were washed and incubated with 1 mL of the
complete medium for additional 42 h. At the end of the
incubation period, the medium was removed, and cells were
washed twice with PBS followed by the fixation of the cells with
1% (w/v) paraformaldehyde in PBS pH 7.4 for 25 min at 37 °C.
Then, cells were washed again with PBS once and incubated
with Hoechst 33342 (5 μM) containing PBS for 10 min at room
temperature. A Zeiss LSM 700 confocal scanning laser
microscope was used for imaging of the cells.
Statistical Analysis.Unless otherwise indicated, all results are
presented as the mean ± standard deviation (SD) calculated
over at least three replicates. The data were analyzed using Prism
7 software (GraphPad); P-values less than 0.05 were considered
to indicate a significant difference.
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■ ABBREVIATIONS
CP, cationic polymer; PEI, polyethylenimine; R, L-arginine;
Spm, spermine; Apd, N-(2-aminoethyl)-1,3-propanediamine;
PA, polyamide; PU, polyurea; PSuA, polysuccinamide; PRA,
arginine-attached polyamide; SAP, solution active polyconden-
sation; EPA, epoxy-polyamide; SpmT4, tetra-p-toluenesulfonate
of spermine; SpmC4, tetrahydrochloride of spermine; ApdT3,
tri-p-toluenesulfonate of N-(2-aminoethyl)-1,3-propanedi-
amine; ApdC3, trihydrochloride of N-(2-aminoethyl)-1,3-
propanediamine; NSu, di-p-nitrophenyl succinate; NtES, di-p-
nitrophenyl-trans-epoxy succinate; NC, di-p-nitrophenyl carbo-
nate; RMeC, arginine-methyl ester dihydrochloride; 1SpmT,
1SpmC, 1ApdT, 1ApdC, spermine and N-(2-aminoethyl)-1,3-
propanediamine based polyureas, where 1 corresponds to the
carbonic acid residue (−CO−), Tmeans p-toluenesulfonate and
C means chloride, accordingly; 2SpmT, 2SpmC, 2ApdT,
2ApdC, spermine and N-(2-aminoethyl)-1,3-propanediamine
based polysuccinamides where 2 corresponds to the succinic
acid residue, T means p-toluenesulfonate and C means chloride,
accordingly; ESpmT, ESpmC, EApdT, EApdC, spermine and
N-(2-aminoethyl)-1,3-propanediamine based intermediate
epoxy-polyamides where E corresponds to the epoxy-succinic
acid residue, T means p-toluenesulfonate and C means chloride,
accordingly; RSpmTC, RSpmCC, RApdTC, RApdCC, sper-
mine and N-(2-aminoethyl)-1,3-propanediamine based poly-
amides with covalently attached arginine-methyl ester hydro-
chloride where RSpmTC and RApdTC are p-toluenesulfonates
and RSpmCC and RApdCC are chlorides, accordingly; HFIP,
hexafluoroisopropanol; PMMA, polymethylmethacrylate;
DMA, dimethylacetamide; TEA, triethylamine; 4T1, murine
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mammary carcinoma; HeLa, human cervical adenocarcinoma;
NIH3T3, mouse fibroblast; CCD 27SK cells, human fibroblast
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